Document Detail


New ether oxime derivatives of erythromycin A. A structure-activity relationship study.
MedLine Citation:
PMID:  1827435     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The discovery of roxithromycin is the result of a rational and scientific process, based on the fact that at least one reason for erythromycin A's resorption variability after oral administration was its instability in the gastric juice. This instability is due to the reactivity of the ketone in position 9 in acidic medium and one chemical approach was to mask it by an oxime function. Both stereoisomers of this oxime were isolated. Direct O-alkylation of this oxime allowed access to various ether oxime derivatives and of the latter the E stereoisomers were more interesting than the Z ones. The choice of the nature of the oxime substitution was made according to the lipophilic or hydrophilic character of the aliphatic ether chain and these alterations were mainly carried out by introducing heteroatoms into this chain. These different derivatives were classified in 5 groups according to the chemical nature of the chain: Aliphatic, aromatic and nitrogen-, oxygen- and sulfur-containing chains. Two classes, those containing a nitrogen or an oxygen in the ether side chains, showed differential in vitro/in vivo antibiotic activities, with improved bioavailability. Some preliminary pharmacokinetic data confirmed this improvement and led to the selection of five candidates, from which roxithromycin emerged as the best compound.
Authors:
J C Gasc; S G d'Ambrieres; A Lutz; J F Chantot
Related Documents :
17373635 - Rapid effects of the intravenous injection of a medium-chain triglyceride: fish oil emu...
17779505 - Branched-chain fatty acids in sediments.
8446425 - Diagnosis and therapy of organic acidurias.
9263455 - Very-long-chain fatty acid biosynthesis is controlled through the expression and specif...
1244195 - In vitro effects of ascorbic acid and dehydroascorbic acid on diphosphopyridine nucleot...
646355 - Bacterial oxidation of polyethylene glycol.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of antibiotics     Volume:  44     ISSN:  0021-8820     ISO Abbreviation:  J. Antibiot.     Publication Date:  1991 Mar 
Date Detail:
Created Date:  1991-06-12     Completed Date:  1991-06-12     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0151115     Medline TA:  J Antibiot (Tokyo)     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  313-30     Citation Subset:  IM    
Affiliation:
Centre de Recherches Roussel Uclaf, Romainville, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bacteria / drug effects*
Biological Availability
Erythromycin / analogs & derivatives*,  pharmacokinetics,  pharmacology,  therapeutic use
Magnetic Resonance Spectroscopy
Mice
Rats
Rats, Inbred Strains
Roxithromycin / pharmacokinetics,  pharmacology*,  therapeutic use
Specific Pathogen-Free Organisms
Staphylococcal Infections / drug therapy*
Stereoisomerism
Streptococcal Infections / drug therapy*
Structure-Activity Relationship
Chemical
Reg. No./Substance:
114-07-8/Erythromycin; 80214-83-1/Roxithromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Gro...
Next Document:  Identification of intracellular calcium pools. Selective modification by thapsigargin.